Homozygous deletion of the STK11/LKB1 locus and the generation of novel fusion transcripts in cervical cancer cells

Cancer Genetics and Cytogenetics

Volumn 197, Issue 2, 2010, Pages 130-141

  McCabe, Michael T ^a,b   Powell, Doris R ^a,b   Zhou, Wei ^a,b   Vertino, Paula M ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE LKB1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SBNO2; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER INCIDENCE; CARCINOGENESIS; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; GENE DELETION; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENE REPRESSION; HELA CELL; HOMOZYGOSITY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ALIGNMENT; TRANSCRIPTION REGULATION; UTERINE CERVIX CANCER;

ALU ELEMENTS; BASE SEQUENCE; CELL LINE, TUMOR; DNA METHYLATION; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; ONCOGENE PROTEINS, FUSION; PROTEIN-SERINE-THREONINE KINASES; RNA, MESSENGER; SEQUENCE ALIGNMENT; TRANSCRIPTION, GENETIC; UTERINE CERVICAL NEOPLASMS;

EID: 77249121152     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.11.017     Document Type: Article

References (55)

1. Hemminki A., Markie D., Tomlinson I., Avizienyte E., Roth S., Loukola A., Bignell G., Warren W., Aminoff M., Hoglund P., Jarvinen H., Kristo P., Pelin K., Ridanpaa M., Salovaara R., Toro T., Bodmer W., Olschwang S., Olsen A.S., Stratton M.R., de la Chapelle A., and Aaltonen L.A. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391 (1998) 184-187
2. Jenne D.E., Reimann H., Nezu J., Friedel W., Loff S., Jeschke R., Muller O., Back W., and Zimmer M. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 18 (1998) 38-43
3. McGarrity T.J., and Amos C. Peutz-Jeghers syndrome: clinicopathology and molecular alterations. Cell Mol Life Sci 63 (2006) 2135-2144
4. Tiainen M., Ylikorkala A., and Makela T.P. Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest. Proc Natl Acad Sci U S A 96 (1999) 9248-9251
5. Makowski L., and Hayes D.N. Role of LKB1 in lung cancer development. Br J Cancer 99 (2008) 683-688
6. Boudeau J., Baas A.F., Deak M., Morrice N.A., Kieloch A., Schutkowski M., Prescott A.R., Clevers H.C., and Alessi D.R. MO25alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm. EMBO J 22 (2003) 5102-5114
7. Hawley S.A., Boudeau J., Reid J.L., Mustard K.J., Udd L., Makela T.P., Alessi D.R., and Hardie D.G. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2 (2003) 28
8. Kemp B.E., Mitchelhill K.I., Stapleton D., Michell B.J., Chen Z.P., and Witters L.A. Dealing with energy demand: the AMP-activated protein kinase. Trends Biochem Sci 24 (1999) 22-25
9. Lizcano J.M., Goransson O., Toth R., Deak M., Morrice N.A., Boudeau J., Hawley S.A., Udd L., Makela T.P., Hardie D.G., and Alessi D.R. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J 23 (2004) 833-843
10. Kojima Y., Miyoshi H., Clevers H.C., Oshima M., Aoki M., and Taketo M.M. Suppression of tubulin polymerization by the LKB1-microtubule-associated protein/microtubule affinity-regulating kinase signaling. J Biol Chem 282 (2007) 23532-23540
11. Mehenni H., Lin-Marq N., Buchet-Poyau K., Reymond A., Collart M.A., Picard D., and Antonarakis S.E. LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes. Hum Mol Genet 14 (2005) 2209-2219
12. Zhong D., Liu X., Khuri F.R., Sun S.Y., Vertino P.M., and Zhou W. LKB1 is necessary for Akt-mediated phosphorylation of proapoptotic proteins. Cancer Res 68 (2008) 7270-7277
13. Avizienyte E., Loukola A., Roth S., Hemminki A., Tarkkanen M., Salovaara R., Arola J., Butzow R., Husgafvel-Pursiainen K., Kokkola A., Jarvinen H., and Aaltonen L.A. LKB1 somatic mutations in sporadic tumors. Am J Pathol 154 (1999) 677-681
14. Sanchez-Cespedes M., Parrella P., Esteller M., Nomoto S., Trink B., Engles J.M., Westra W.H., Herman J.G., and Sidransky D. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res 62 (2002) 3659-3662
15. Zhong D., Guo L., de Aguirre I., Liu X., Lamb N., Sun S.Y., Gal A.A., Vertino P.M., and Zhou W. LKB1 mutation in large cell carcinoma of the lung. Lung Cancer 53 (2006) 285-294
16. Matsumoto S., Iwakawa R., Takahashi K., Kohno T., Nakanishi Y., Matsuno Y., Suzuki K., Nakamoto M., Shimizu E., Minna J.D., and Yokota J. Prevalence and specificity of LKB1 genetic alterations in lung cancers. Oncogene 26 (2007) 5911-5918
17. Su G.H., Hruban R.H., Bansal R.K., Bova G.S., Tang D.J., Shekher M.C., Westerman A.M., Entius M.M., Goggins M., Yeo C.J., and Kern S.E. Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol 154 (1999) 1835-1840
18. Sato N., Rosty C., Jansen M., Fukushima N., Ueki T., Yeo C.J., Cameron J.L., Iacobuzio-Donahue C.A., Hruban R.H., and Goggins M. STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol 159 (2001) 2017-2022
19. Guldberg P., thor Straten P., Ahrenkiel V., Seremet T., Kirkin A.F., and Zeuthen J. Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma. Oncogene 18 (1999) 1777-1780
20. Wingo S.N., Gallardo T.D., Akbay E.A., Liang M.C., Contreras C.M., Boren T., Shimamura T., Miller D.S., Sharpless N.E., Bardeesy N., Kwiatkowski D.J., Schorge J.O., Wong K.K., and Castrillon D.H. Somatic LKB1 mutations promote cervical cancer progression. PLoS One 4 (2009) e5137
21. Kuragaki C., Enomoto T., Ueno Y., Sun H., Fujita M., Nakashima R., Ueda Y., Wada H., Murata Y., Toki T., Konishi I., and Fujii S. Mutations in the STK11 gene characterize minimal deviation adenocarcinoma of the uterine cervix. Lab Invest 83 (2003) 35-45
22. Conway K.E., McConnell B.B., Bowring C.E., Donald C.D., Warren S.T., and Vertino P.M. TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers. Cancer Res 60 (2000) 6236-6242
23. McCabe M.T., Lee E.K., and Vertino P.M. A multifactorial signature of DNA sequence and polycomb binding predicts aberrant CpG island methylation. Cancer Res 69 (2009) 282-291
24. Bamford S., Dawson E., Forbes S., Clements J., Pettett R., Dogan A., Flanagan A., Teague J., Futreal P.A., Stratton M.R., Wooster R., and The C.O.S.M.I.C. (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer 91 (2004) 355-358
25. Alessi D.R., Sakamoto K., and Bayascas J.R. LKB1-dependent signaling pathways. Annu Rev Biochem 75 (2006) 137-163
26. Esteller M., Avizienyte E., Corn P.G., Lothe R.A., Baylin S.B., Aaltonen L.A., and Herman J.G. Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome. Oncogene 19 (2000) 164-168
27. Qanungo S., Haldar S., and Basu A. Restoration of silenced Peutz-Jeghers syndrome gene, LKB1, induces apoptosis in pancreatic carcinoma cells. Neoplasia 5 (2003) 367-374
28. Puck T.T., Marcus P.I., and Cieciura S.J. Clonal growth of mammalian cells in vitro; growth characteristics of colonies from single HeLa cells with and without a feeder layer. J Exp Med 103 (1956) 273-283
29. Batzer M.A., and Deininger P.L. Alu repeats and human genomic diversity. Nat Rev Genet 3 (2002) 370-379
30. Sen S.K., Han K., Wang J., Lee J., Wang H., Callinan P.A., Dyer M., Cordaux R., Liang P., and Batzer M.A. Human genomic deletions mediated by recombination between Alu elements. Am J Hum Genet 79 (2006) 41-53
31. Han K., Lee J., Meyer T.J., Wang J., Sen S.K., Srikanta D., Liang P., and Batzer M.A. Alu recombination-mediated structural deletions in the chimpanzee genome. PLoS Genet 3 (2007) 1939-1949
32. King D.C., Taylor J., Elnitski L., Chiaromonte F., Miller W., and Hardison R.C. Evaluation of regulatory potential and conservation scores for detecting cis-regulatory modules in aligned mammalian genome sequences. Genome Res 15 (2005) 1051-1060
33. Davuluri R.V., Grosse I., and Zhang M.Q. Computational identification of promoters and first exons in the human genome. Nat Genet 29 (2001) 412-417
34. Down T.A., and Hubbard T.J. Computational detection and location of transcription start sites in mammalian genomic DNA. Genome Res 12 (2002) 458-461
35. Rhodes D.R., Kalyana-Sundaram S., Mahavisno V., Varambally R., Yu J., Briggs B.B., Barrette T.R., Anstet M.J., Kincead-Beal C., Kulkarni P., Varambally S., Ghosh D., and Chinnaiyan A.M. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 9 (2007) 166-180
36. Pyeon D., Newton M.A., Lambert P.F., den Boon J.A., Sengupta S., Marsit C.J., Woodworth C.D., Connor J.P., Haugen T.H., Smith E.M., Kelsey K.T., Turek L.P., and Ahlquist P. Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res 67 (2007) 4605-4619
37. Korkola J.E., Houldsworth J., Chadalavada R.S., Olshen A.B., Dobrzynski D., Reuter V.E., Bosl G.J., and Chaganti R.S. Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Res 66 (2006) 820-827
38. Boudeau J., Sapkota G., and Alessi D.R. LKB1, a protein kinase regulating cell proliferation and polarity. FEBS Lett 546 (2003) 159-165
39. Connolly D.C., Katabuchi H., Cliby W.A., and Cho K.R. Somatic mutations in the STK11/LKB1 gene are uncommon in rare gynecological tumor types associated with Peutz-Jegher's syndrome. Am J Pathol 156 (2000) 339-345
40. Cui B., Zheng B., Zhang X., Stendahl U., Andersson S., and Wallin K.L. Mutation of PIK3CA: possible risk factor for cervical carcinogenesis in older women. Int J Oncol 34 (2009) 409-416
41. Kolomietz E., Meyn M.S., Pandita A., and Squire J.A. The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors. Genes Chromosomes Cancer 35 (2002) 97-112
42. Deininger P.L., and Batzer M.A. Alu repeats and human disease. Mol Genet Metab 67 (1999) 183-193
43. Oliveira C., Senz J., Kaurah P., Pinheiro H., Sanges R., Haegert A., Corso G., Schouten J., Fitzgerald R., Vogelsang H., Keller G., Dwerryhouse S., Grimmer D., Chin S.F., Yang H.K., Jackson C.E., Seruca R., Roviello F., Stupka E., Caldas C., and Huntsman D. Germline CDH1 Deletions in hereditary diffuse gastric cancer families. Hum Mol Genet 18 (2009) 1545-1555
44. Aissi-Ben Moussa S., Moussa A., Lovecchio T., Kourda N., Najjar T., Ben Jilani S., El Gaaied A., Porchet N., Manai M., and Buisine M.P. Identification and characterization of a novel MLH1 genomic rearrangement as the cause of HNPCC in a Tunisian family: evidence for a homologous Alu-mediated recombination. Fam Cancer 8 (2009) 119-126
45. Fukuuchi A., Nagamura Y., Yaguchi H., Ohkura N., Obara T., and Tsukada T. A whole MEN1 gene deletion flanked by Alu repeats in a family with multiple endocrine neoplasia type 1. Jpn J Clin Oncol 36 (2006) 739-744
46. Ward B.D., Hendrickson B.C., Judkins T., Deffenbaugh A.M., Leclair B., Ward B.E., and Scholl T. A multi-exonic BRCA1 deletion identified in multiple families through single nucleotide polymorphism haplotype pair analysis and gene amplification with widely dispersed primer sets. J Mol Diagn 7 (2005) 139-142
47. Liu W., Ewing C.M., Chang B.L., Li T., Sun J., Turner A.R., Dimitrov L., Zhu Y., Sun J., Kim J.W., Zheng S.L., Isaacs W.B., and Xu J. Multiple genomic alterations on 21q22 predict various TMPRSS2/ERG fusion transcripts in human prostate cancers. Genes Chromosomes Cancer 46 (2007) 972-980
48. Hsieh S.Y., Chen W.Y., Yeh T.S., Sheen I.S., and Huang S.F. High-frequency Alu-mediated genomic recombination/deletion within the caspase-activated DNase gene in human hepatoma. Oncogene 24 (2005) 6584-6589
49. Dabora S.L., Nieto A.A., Franz D., Jozwiak S., Van Den Ouweland A., and Kwiatkowski D.J. Characterisation of six large deletions in TSC2 identified using long range PCR suggests diverse mechanisms including Alu mediated recombination. J Med Genet 37 (2000) 877-883
50. Futreal P.A., Coin L., Marshall M., Down T., Hubbard T., Wooster R., Rahman N., and Stratton M.R. A census of human cancer genes. Nat Rev Cancer 4 (2004) 177-183
51. Soda M., Choi Y.L., Enomoto M., Takada S., Yamashita Y., Ishikawa S., Fujiwara S., Watanabe H., Kurashina K., Hatanaka H., Bando M., Ohno S., Ishikawa Y., Aburatani H., Niki T., Sohara Y., Sugiyama Y., and Mano H. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448 (2007) 561-566
52. Tomlins S.A., Rhodes D.R., Perner S., Dhanasekaran S.M., Mehra R., Sun X.W., Varambally S., Cao X., Tchinda J., Kuefer R., Lee C., Montie J.E., Shah R.B., Pienta K.J., Rubin M.A., and Chinnaiyan A.M. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310 (2005) 644-648
53. Maher C.A., Kumar-Sinha C., Cao X., Kalyana-Sundaram S., Han B., Jing X., Sam L., Barrette T., Palanisamy N., and Chinnaiyan A.M. Transcriptome sequencing to detect gene fusions in cancer. Nature 458 (2009) 97-101
54. Campbell P.J., Stephens P.J., Pleasance E.D., O'Meara S., Li H., Santarius T., Stebbings L.A., Leroy C., Edkins S., Hardy C., Teague J.W., Menzies A., Goodhead I., Turner D.J., Clee C.M., Quail M.A., Cox A., Brown C., Durbin R., Hurles M.E., Edwards P.A., Bignell G.R., Stratton M.R., and Futreal P.A. Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat Genet 40 (2008) 722-729
55. Marignani P.A., Kanai F., and Carpenter C.L. LKB1 associates with Brg1 and is necessary for Brg1-induced growth arrest. J Biol Chem 276 (2001) 32415-32418